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Abstract
Background: The production of integral membrane spanning proteins (IMP’s) constitutes a bottleneck in
pharmaceutical development. It was long considered that the state-of-the-art was to produce the proteins as
inclusion bodies using a powerful induction system. However, the quality of the protein was compromised and the
production of a soluble protein that is incorporated into the membrane from which it is extracted is now
considered to be a better method. Earlier research has indicated that a slower rate of protein synthesis might
overcome the tendency to form inclusion bodies. We here suggest the use of a set of E. coli mutants characterized
by a slower rate of growth and protein synthesis as a tool for increasing the amount of soluble protein in high-
throughput protein production processes.
Results: A set of five IMP’s was chosen which were expressed in three mutants and the corresponding WT cell
(control). The mutations led to three different substrate uptake rates, two of which were considerably slower than
that of the wild type. Using the mutants, we were able to express three out of the five membrane proteins. Most
successful was the mutant growing at 50% of the wild type growth rate. A further effect of a low growth rate is a
low acetic acid formation, and we believe that this is a possible reason for the better production. This hypothesis
was further supported by expression from the BL21(DE3) strain, using the same plasmid. This strain grows at a high
growth rate but nevertheless yields only small amounts of acetic acid. This strain was also able to express three
out of the five IMP’s, although at lower quantities.
Conclusions: The use of mutants that reduce the specific substrate uptake rate seems to be a versatile tool for
overcoming some of the difficulties in the production of integral membrane spanning proteins. A set of strains
with mutations in the glucose uptake system and with a lower acetic acid formation were able to produce three
out of five membrane proteins that it was not possible to produce with the corresponding wild type.
Background
The production of recombinant proteins is generally
considered to be a burden on the host cell. In severe
cases, protein expression cannot be pursued at all or
leads to the accumulation of degraded protein or of pro-
tein which is precipitated in the form of inclusion
b o d i e s .A tt h es a m et i m e ,e x pression may be accompa-
nied by a high degree of cell death in the population
that reduces the total yield and productivity. Except for
rare cases, it is difficult to pinpoint the exact mechanism
behind this malfunction. Each protein is unique and the
steps in the synthesis of an active protein are many.
A common way to overcome expression difficulties is
to lower the temperature, which is a parameter that can
be used regardless of expression system and protein.
The reason why this is efficient in a particular case is
however difficult to identify since the temperature
affects a large number of cellular mechanisms as well as
all the equilibrium constants. A temperature decrease
will thus have an impact on both positive and negative
reactions controlling the specific protein production,
and this explains why this strategy is often not success-
ful. The reduction in temperature however always leads
to a slower growth rate and thus a slower rate of protein
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that a lower synthesis rate will allow the cell to over-
come important bottlenecks such as folding and the rate
of translocation between cell compartments. Especially
in membrane protein production, it has been clearly
s h o w nt h a tw h e nas t r o n gi n d u c t i o ns y s t e ml i k et h e
BL21(DE3) strain is used, it is indeed the high and
immediate rate of protein-specific mRNA accumulation,
resulting from high level T7 RNA polymerase produc-
tion, that has detrimental effects on the host cell and
thus lowers the product yield [1-3].
We have earlier shown that a reduction in the growth
rate, in our case caused not by a temperature reduction
but by a restricted feed of the carbon source, has a large
impact on recombinant protein production [4-6]. A
lower growth rate was shown to result in a lower cell-
specific rate of production of the recombinant protein
although the specific mRNA level, i.e. the transcription
rate, was the same. The lower rate of protein synthesis
here was probably due to a lower translation rate since
the lower substrate uptake rate resulted in a smaller
amount of ribosomes. The total protein production was
not however impaired since a longer cultivation time led
to the same amount of protein accumulation. The great
benefits of the system were less proteolytic degradation
of the protein and less inclusion body formation. The
relatively slower synthesis rate of the recombinant pro-
tein is thus important for the quality of the protein pro-
duct, and it seems to be particularly important in the
production of membrane proteins which are preferably
produced in a soluble membrane fraction [7].
During the development of new pharmaceutical drugs,
one of the goals is to rapidly deliver small soluble quanti-
ties of a large number of proteins and protein variants for
further studies of their structure and function in relation
to disease control. To avoid bottlenecks, the most favor-
able conditions are chosen with respect to expression
system and medium. In order to screen a number of dif-
ferent proteins, production takes place in a multiparallel
unsupervised format (HTP, High Throughput Protein
production) which leads to uncontrolled process condi-
tions with respect to important parameters such as pH,
acetic acid production and oxygenation, and therefore to
low cell densities and low product concentrations. No
variation in the production scheme can be allowed and
all clones are induced simultaneously and are harvested
at the same time, which means that the cultivation time
for all the cells is the same.
The development of a commercial protein production
process, on the other hand, allows the measurement and
control of a number of parameters, resulting in a range
of actions that can be taken to increase the productivity
and to keep important parameters constant. The process
is carefully sampled and optimized during the process
development. The most important control technique
used is the fed-batch technique, which allows the accu-
mulation of high cell densities but also the metabolic
control of acetic acid production. This is achieved by
operator control of the supply of the glucose which is
fed to the cultivation, in order to restrict the glucose
uptake by the individual cell.
In order to take advantage of the important process
control strategies of the commercial production process
during HTP, we have used a set of E. coli mutants
which are deficient in their glucose uptake due to dele-
tions in the phosphoenolpyruvate:phosphotransferase
system (PTS). Since these cells have a reduced glucose
uptake, they have on a cellular level all the advantages
generally associated with the fed-batch concept [8]. The
restricted rates of growth and substrate uptake of these
cells were shown to affect not only the growth rate but
also the formation of overflow byproducts like acetic
acid. Earlier studies have shown that this acid not only
limits the cell density but also has a major impact on
the growth rate and on the production of human growth
hormone in E. coli [9].
The goal of the present work was to understand
whether the mutants in the glucose uptake system could
be used under the conditions which characterise the
small-scale multi-parallel production format and thus
lead to greater success in soluble protein accumulation.
The targets of the investigation were integral membrane
spanning proteins (IMP’s). We also aimed to ascertain
whether it is the substrate uptake rate or the acetic acid
formation that has the greater influence on the soluble
IMP production.
Materials and methods
Cloning
A blunt-ended GW-cassette (from Invitrogen’sG a t e w a y
Conversion kit) was inserted into the SmaI-digested
pBluescript intermediate construct yielding pBS-GW. A
clone with the correct orientation of the GW-cassette in
frame A was chosen by digestion with EcoI. pBADHisA
(Invitrogen) was digested with NheIa n dHindIII. pBS-
GW was digested with SpeIa n dHindIII and was ligated
into the precut pBADHisA, yielding BADHisA-frame A
GW.
This construct was transformed into DB3.1 cells (Z-
competent, in-house production). Transformants were
grown on LB agar plates containing 34 μg/ml chloram-
phenicol. Colonies were selected and grown in liquid
cultures for subsequent plasmid preparation (QIAprep
Spin Miniprep Kit (Qiagen)). The plasmids were test
digested with NcoI. A clone with the correct size of the
digested fragment was sent for sequencing (Eurofinsdna,
Germany) to verify the correct insertion of the GW-
cassette.
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EM20, EM29 [7] were used as entry clones. Site-specific
recombination catalysed by the LR clonase enzyme mix
(Invitrogen) was used in order to subclone the entry
clones into the destination vector pBADHisA-frame A
GW. The identities of the constructs were verified by
sequencing (Eurofinsdna, Germany).
The resulting expression vectors, all expressing the
proteins from the arabinose promoter, were transformed
into E. coli BL21(DE3) (derived from the original Nova-
gen stock), AF1000 (MC4100 relA
+), PPA668 (ptsM),
PPA652 (ptsG) and PPA689 (ptsG, ptsM) [8].
Cultivation medium
A minimal salt media was used which consisted of
(per litre): 7 g (NH4)2SO4;1 . 6gK H 2PO4;6 . 6gN a 2H-
PO4*2H2Oa n d0 . 5g( N H 4)2-H-Citrate. The medium
was supplemented with 1 ml/l trace element solution
[8] and1 ml/l 1 M MgSO4 and 10 g/l glucose. 100 μg/
ml carbenicilin was added to cells containing
plasmids.
Small-scale protein overexpression
200 μl of overnight culture was used to inoculate 1.8 ml
of medium. The cells were grown in 24-well plates at
37°C at 1350 rpm. Induction was performed by the
addition of 0.2% arabinose when the cells had reached
an OD600 of approximately 0.5. 1 ml of the cultures was
harvested three hours after the induction. The pellets
were stored at -20°C.
Small-scale protein purification
Small-scale IMAC with Ni
2+-resin was used for purifica-
tion of the proteins in 96-well format. 25 μlN i - N T A
(Invitrogen) was added to a 0.65 μm filter plate (Milli-
pore) that was centrifuged for 1 min at 100 g. The plate
was washed with 100 μlm Q - H 2O and equilibrated with
200 μl wash buffer (20 mM Tris-HCl, 300 mM NaCl, 40
mM Imidazole, 0.1% FC12 (Anatrace) and 0,5 mM
TCEP).
The pellets from the small-scale cultivation were
thawed and resuspended in 100 μl lysis buffer (20 mM
Tris pH 8, 100 mM NaCl, 1 mg/ml lysozyme (Sigma),
10 U/ml benzonase (Novagen), 1% FC12 and one tablet
Complete Protease Inhibitor EDTA-free (Roche) per 22
ml buffer). The suspension was incubated at 1000 rpm
at 4°C for 30 min and centrifuged for 30 min at 3000 g
at 4°C.
The Ni-plate was prepared by centrifugation for 1 min
at 100 g. The clarified cell lysate was added to the Ni-
plate that was then incubated for 15 min at 4°C at 600
rpm and centrifuged for 1 min at 100 g. The resin was
washed three times with 200 μl wash buffer and eluted
by addition of 25 μl elution buffer (20 mM Tris-HCl pH
8, 300 mM NaCl, 500 mM Imidazole, 0,5 mM TCEP
and 0.1% FC-12) followed by centrifugation at 100 g for
1 min at 4°C.
Dot blot analysis
1.5 μl of the eluate was applied to a nitrocellulose mem-
brane and allowed to dry. The membrane was incubated
overnight at 4°C in a blocking solution consisting of 1%
BSA in TBS-T pH 7.5. The membranes were washed
three times for 10 min with TBS-T and incubated for
one hour with His-probe-HRP (Pierce) diluted 1:5000 in
TBS-T. The membranes were washed three times for 10
min with TBS-T and developed with Super Signal
®
West Pico (Pierce) according to the manufacturer’s
recommendations. The signals were detected with the
FluorS-MultiImager (BioRad).
Medium-scale protein overexpression
Target EM03 was expressed in medium-scale liquid cul-
tures (400 ml). 360 ml medium was inoculated with 40
ml of the overnight culture. The cells were grown at 37°
Ca t2 0 0r p mu n t i lt h e yr e a c h e da nO D 600 of approxi-
mately one unity when induction with 0.2% arabinose
took place. OD600 was measured and cells from a 100
ml suspension were harvested by centrifugation at 5000
g for 10 min at 4°C three hours after the induction. The
pellets were stored at -80°C.
Membrane protein extraction
The frozen pellets were thawed. 15 ml of lysis buffer (20
mM Na-P, 300 mM NaCl, 0.5 mM DTT, 5 U/mL
DNase, 1 mg/ml lysozyme, 30 mM Imidazole and one
tablet Complete Protease Inhibitor EDTA-free per 100
ml buffer) was added to each pellet. The suspension was
agitated at 1000 rpm at 4°C for 40 min. The samples
were sonicated and centrifuged at 10000 g for 10 min at
4°C. 7.5 ml of the supernatant was centrifuged at 35000
g for one hour in order to harvest the membranes. The
membrane pellet was resuspended in 3 ml solubilisation
buffer (20 mM Na-P, 300 mM NaCl, 30 mM Imidazole
pH 7.5, 0.5 mM DTT and one tablet Complete Protease
Inhibitor EDTA-free per 100 ml) per 200 OD600 units of
former cells.
The membranes were resuspended by shaking and
homogenised using a glass homogenizer. A small aliquot
was taken for SDS-PAGE analysis. The samples were
mixed with NuPAGE
® Sample Reducing Agent and
NuPAGE
® LDS Sample buffer (Invitrogen). 15 μlo ft h e
s a m p l e sw e r er u no naN u P A G E
® 4-12% Bis-Tris gel
using NuPAGE
® MES buffer system (Invitrogen). See-
Blue
® Plus2 (Invitrogen) was used as marker. The gels
were stained with Coomassie brilliant blue to visualize
the protein bands. The remaining samples were stored
at -80°C.
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FC-12 was added to the thawed samples to a final con-
centration of 1% following incubation during shaking at
1000 rpm at 4°C and centrifugation at 30000 g for 30
min at 4°C. 250 μl Ni-NTA agarose resin was prepared
by washing with 5 ml water and 2 ml elution buffer (20
mM Na-P, 150 mM NaCl, 400 mM Imidazole, pH 7.5,
0.5 mM DTT, 0.1% FC12) and equilibrated with 2 ml
wash buffer 1 (20 mM Na-P, 300 mM NaCl, 30 mM
Imidazole, pH 7.5, 0.5 mM DTT, 0,1% FC12). The sam-
ples were added to the resins and incubated for 10 min
at 4°C, followed by the addition of wash buffer 1 (2 × 2
ml) and wash buffer 2 (2 × 2 ml) (20 mM Na-P, 300
mM NaCl, 40 mM Imidazole, pH 7.5, 0.5 mM DTT,
0.1% FC-12). Bound proteins were eluted with 1500 μl
elution buffer. The samples were concentrated to a
volume of 250 μl using a 30 kDa cut-off filter. A small
aliquot of each sample was analyzed by SDS-PAGE as
described above. 15 μl of each sample was loaded to
lane 2, 3, 5 and 6 and 7 μl to lane 4.
Analytical gel filtration
15 μl of the samples were loaded in duplicates on a
Superdex™ 200 5/150 GL column (GE Healthcare). The
buffer was Hepes pH 7.5. The yields were calculated by
measuring the absorbance at 280 nm. The chromato-
gram shows values for the same amounts of OD600 units
of cells, normalized so that the top peak absorbance was
1.
The areas beneath the curves in the chromatograms
were calculated in order to compare the amounts of
protein produced in the different strains. The diagram
shows peak areas for the same amounts of OD600 units
of cells, normalized so that the top peak area was 1.
Acetate production
The cells were grown in 500 ml medium at 37°C at 180
rpm, in order to determine the amount of acetic acid
produced per OD600 unit of cells. A 6 ml sample of cell
suspension was taken every hour. 1 ml was used to
determine the OD600 and 5 ml was centrifuged for 10
min at 4500 rpm at 4°C. The supernatant was sterile fil-
tered (Sartorius, 0.2 μm) and the acetate concentration
was determined using a commercial enzymatic kit
(Boehringer-Mannheim no. 148261). Each sample was
tested four times and the mean value was calculated.
Results
The aim of this study was to understand whether a
reduction in the growth rate/substrate uptake rate would
lead to a greater success in the production of soluble
integral membrane spanning proteins in E. coli. For this
purpose we used a set of strains that was constructed
[10] to carry deletions in the phosphoenolpyruvate
carbohydrate:phosphotransferase system (PTS), responsi-
ble for the uptake of various sugars in E. coli [11]. These
strains and the corresponding wild type (AF1000), which
are K-derivatives, are listed in Table 1. The mutants are
characterized by their inability to take up glucose
through the deleted permeases: (i) a defective enzyme
IIAB
Man, which unspecifically controls the uptake of
mannose but also allows glucose passage (ptsM), (ii) a
defective enzyme IIBC
Glc (ptsG), specific for glucose
uptake, and (iii) the double mutant (ptsG,ptsM), in which
glucose is taken up by symport. The commercial strain
BL21(DE3), which is a B-derivative, was also included
since this strain is often used for the production of IMP’s
[1,7,12,13] The production was controlled by the same
vector as for the AF1000 strains.
The effect of the mutations on growth rate is shown
in Table 1. It is clear that the removal of the glucose
permease (ptsG) effectively reduces the rate of growth at
high glucose concentrations. It should be noted that a
minimal salts medium was used with glucose as carbon
source and that no complex components were added to
the medium, in order to avoid the interference of e.g. a
lack of specific amino acids on the protein production.
Five E. coli membrane spanning integral proteins
(IMP’s) with human homologues were selected for the
study and were produced with N-terminal His6 tags to
facilitate purification. The proteins and their characteris-
tics are listed in Table 2. Some of these proteins were
considered difficult to express in earlier studies [7] using
the C41(DE3) strain, i.e. the BL21(DE3) mutant first
described by Miroux and Walker [1].
The IMP’s were cloned and induced from the arabi-
nose promoter in all strains and grown on microtitre
plates. A dot blot was used to show the expression of
the targets in the different strains (Figure 1). The
mutants carrying the glucose permease mutation were
able to produce three out of the five proteins, as was
the BL21(DE3) strain. There are no obvious reasons for
the difficulty in producing the two remaining proteins,
at least not with respect to the amount of a-helix mem-
brane spanning units, which varied in a random fashion
from six to twelve. The cells were induced at an OD600
Table 1 Strain characterization
Strain Specific growth rate Mutation
(h
-1)
AF1000 0,05 -
PPA668 0,78 ptsM
PPA652 0,38 ptsG
PPA689 0,25 ptsG, ptsM
BL21(DE3) 0,76 -
Strains used in the study and their corresponding specific growth rates in
minimal salt medium supplemented with glucose at 37°C.
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same time of expression (three hours). The amounts of
cells at the time of harvest varied since the strains have
different growth rates. A quantitative comparison of the
expression levels in the different strains is not therefore
possible from this dot blot.
In order to be able to compare the relative amounts of
IMP’s and to assess the degree of homogeneity of the
target proteins, we scaled up the production of the
EM03 protein into shake flasks. The composition of the
membrane protein isolation fraction is shown by SDS-
PAGE in Figure 2. The EM03 48 kDa protein was pro-
d u c e do n l yb yt h eg l u c o s ep e r m e a s em u t a n t sa n dt h e
BL21(DE3) strain, which supports the dot blot results.
The samples were subjected to IMAC resin in order to
purify the His6-tagged product. The expression of the
target protein was verified by Comassie-stained SDS-
PAGE (Figure 3).
The samples were further subjected to analytical gel
filtration to allow a quantitative comparison of the
expression levels in the different strains. The gel filtra-
tion chromatogram is shown in Figure 4A where values
for the same amounts of cells are shown normalized so
that the top peak (maximum) value equals 1. The chro-
matogram shows that EM03 could be purified as a non-
aggregate.
The amounts of EM03 that were produced in the dif-
ferent strains was calculated from the areas under the
curves and the results are plotted in Figure 4B. The
comparison shows that the glucose permease mutant
produced approximately twice as much protein as the
double mutant and BL21(DE3). The wild type and the
mannose permease mutant, which both take up glucose
at the same high rate, produced very small quantities of
EM03, so that it was not possible to determine the areas
in a statistically relevant fashion.
Since the BL21(DE3) strain was qualitatively as good a
producer as the glucose permease mutants, in spite of
its high specific growth rate, additional experiments
were performed to clarify this issue. Since the lower
Table 2 Membrane protein characteristics
Target NCBI Reference Sequence Predicted Function
EM03 ZP_03069574.1 Ammonium transporter
EM09 NP_418444.1 Predicted transporter
EM16 ABV06797.1 Chloride transporter, chloride channel (CIC) family
EM20 NP_418166.1 Multidrug efflux system protein
EM29 NP_756065.1 Intramembrane serine protease GlpG
The integral membrane proteins used in the study.
    

		
		
		


Figure 1 Expression of membrane proteins. Dot blot of purified
His-tag proteins overexpressed in the following strains: AF1000,
PPA668, PPA652, PPA689 and BL21(DE3). See Table 1 for the strain
characteristics. The cells were grown on microtitre plates and were
induced with 0.2% arabinose at 37°C.
Figure 2 Analysis of the membrane protein fraction.S D S - P A G E
analysis containing membrane fractions from medium-scale shake
flask cultivations. The target EM03 is indicated by an arrow. The
lanes were loaded in the following way: 1 marker, 2 AF1000, 3
PPA668, 4 PPA652, 5 PPA689, 6 BL21(DE3).
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production of acetic acid, the acetic acid production was
further studied in all the strains. It was measured in
shake cultivations and the yield of acid per cell is shown
i nT a b l e3 .I ti sh e r en o t a b l et h a tt h eB L 2 1 ( D E 3 )s t r a i n
had a comparatively low production of the acid at high
glucose concentrations, although the growth rate was as
high as in the wild type K-12 strain AF1000. The glu-
cose permease mutants, on the other hand, show almost
no overflow metabolism, although the glucose concen-
tration is 10 g/L.
Discussion
E. coli BL21(DE3) seems to be the dominant choice for
the production of membrane proteins for the purpose of
solving their structures and the characterization of their
functions [12]. Membrane proteins are in some cases
produced by this strain, but the product usually appears
as inclusion bodies [1], and this is generally undesirable
due to downstream problems [12]. It is also clear that
relatively few membrane protein structures have today
been solved and furthermore that until 2005, more than
70% of the solved structures were of non-eukaryotic
origin [12]. The lack of good protein production meth-
ods is thought to be one of the dominant factors behind
the low success [13].
Miroux and Walker have shown that the production
of eukaryotic membrane proteins with the BL21(DE3)-
system is generally very toxic to the cells and that most
of them did not even survive induction [1]. They thus
developed the BL21(DE3) mutant strains, C41(DE3) and
C43(DE3), the “Walker strains”,w h i c hs e e m st ob e
much better suited for production. Through subsequent
genomic and proteomic studies [3], it was shown that
the original PlacUV5promoter of these strains, which is
generally stronger than the original Plac variant, had
reverted to the original wild type sequence. It was
clearly shown that the lower strength of the lac promo-
ter led to a lower transcription rate of the T7 RNA
polymerase, and that this in turn, had a positive effect
on the cellular viability leading to higher total produc-
tion levels. The mechanism by which the viability is
restored has not yet been revealed. Wagner and cowor-
kers suggested that it was due to the lower rate of tran-
scription of the membrane protein, due to a decreased
T7RNAP synthesis, and used this to modulate these
levels using a tunable T7Lys expression system [3]. This
resulted in increased cell viability and in several cases
also to an increase in the total production. In some
cases, however, the use of C41(DE3) and C43(DE3) gave
still better results. The tuning of T7RNAP levels was
already suggested by Miroux and Walker [1], but with
the comment that it might not be altogether successful
for the difficult eukaryotic membrane proteins that still
remain to be successfully produced.
In this paper, we have described a different approach
to membrane protein production by reducing the sub-
strate uptake rate, and thus indirectly the protein synth-
esis rate, using the PTS-mutants. The production is
introduced on low copy number plasmids with tunable
promoter properties. The advantage, besides a lower
synthesis rate, is that it avoids the ATP-costly transcrip-
tion of specific messengers, which we believe to be an
additional reason for the reduction in cell viability upon
induction. In many cases in the literature it has been
indicated that the cell after induction is lacking energy
and will seek alternative sources for the supply of both
carbon and energy, which can lead to e.g. ribosome
degradation since these are by far the largest cellular
resources available [5,14]. Energy-costly processes
should thus be avoided as far as possible to save the cell
from internal degradation.
Another large drawback of production systems invol-
ving elements of periplasmic or outer membrane trans-
port is the possible saturation of the inner membrane
secretory system (Sec), and this seemed to be another
consequence of high and rapid membrane protein
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Figure 3 Verification of expression of the target protein.S D S -
PAGE analysis of IMAC-purified target EM03. The lanes were loaded
in the following way: 1 marker, 2 AF1000, 3 PPA668, 4 PPA652, 5
PPA689, 6 BL21(DE3).
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[2]. The accumulation of precursors of periplasmic and
outer membrane proteins in the cytosol is of course
also a waste of building blocks and energy. In the
same study it was also shown that overexpression leads
to the induction of the acetate-phosphotransacetylate
pathway probably because of the need for additional
energy which, under these particular circumstances,
might not be possible to obtain by increased oxidative
phosphorylation.
The glucose permease mutants and the BL21(DE3)
strain, all induced by arabinose, are described in this
paper as being equally effective in protein expression, as
we were able to express three out of five proteins with
all of them. However, the yield of protein per cell for
the PPA652 mutant was twice as high as for the other
producing systems. The glucose permease mutants grow
more slowly than the BL21(DE3) cells and therefore
need approximately twice the time (approx 7 h) to reach
the same cell density. The mutant cells can however
grow to a higher cell density since they produce no
acetic acid, and this may lead to an even further
increase in the total production level. This ability has
earlier been shown when mutants were grown in a fer-
menter to an OD600 of approximately 100 [8]. The limit
is set by the oxygen-transfer capacity, which in the fer-
menter is characterized by a KLa of approx 800 h
-1
Figure 4 Purification and quantification of the selected membrane protein target. (A) Analytical gel filtration from medium-scale shake
flask cultivations using the target protein, EM03. The chromatogram shows values for an equal OD600 -value of cells in the different samples,
normalized with respect to the highest top peak absorbance set equal to one. (B) Estimated peak areas of analytical gel filtration chromatograms
from the production of the target EM03. The values show calculated peak areas for an equal OD600 -value of cells in the different samples,
normalized with respect to the largest top peak area set equal to one.
Table 3 Acetic acid production
Strain HAc
(mg/l) per OD600-unit
AF1000 158
PPA668 147
PPA652 3
PPA689 2
BL21(DE3) 58
Cell-specific acetic acid production of the strains used in the study.
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mately 130 - 188 h
-1 [15,16]. Theoretically, this compari-
son should allow an OD600 of approximately 20 on the
best plates using the mutants when no acetic acid is
formed, which is about 5 times higher than the density
reached today.
The question of whether it is the low growth rate or
the lack of acetic acid production that is the reason for
the better production has not been totally clarified. The
data suggest the latter, since BL21(DE3), in spite of its
high growth rate, shows similar production results to
our glucose permease mutants, and the reason could
then be the low acetic acid production of BL21(DE3) at
high glucose concentrations in minimal medium. The
reason why this B strain is not subject to overflow meta-
bolism in the same way as the K-12 strains has, to our
knowledge, not been explained in detail. It has however
been suggested that B-strains have a more active glyoxy-
late shunt than K-12 strains [17], which results in the
direction of pyruvate into other metabolic functions and
in the reduction of acetic acid formation.
The comparative data presented in Figure 4 and Table
3 also suggest that the lower the acetic acid production
the higher is the protein production. This is not how-
ever the only factor that is important, since it seems
that a too low glucose uptake, maybe only leading to
maintenance levels of glucose in the double mutant, also
reduces production. This again suggests the importance
of a high-energy status of the cell.
Conclusions
The use of PTS mutants that slow down the specific
growth rate seems to be a versatile tool to overcome
some of the difficulties in the production of integral
membrane spanning proteins. A set of strains with
mutations in the glucose PTS-uptake system exhibiting
a lower acetic acid production, were able to produce
three out of five membrane proteins, which was impos-
sible with the corresponding wild type. Not only were
these proteins expressed but also in relatively larger
quantities than with the commonly used BL21(DE3)
strain using the same induction system. This means that
this methodology can be used for other membrane pro-
teins, as well as for difficult-to-express proteins that are
desired to be soluble in the cytoplasm.
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